giovedì, 28 settembre 2023
26 Agosto 2016

ASCO and SGO Release Clinical Practice Guideline on Neoadjuvant Therapy for Newly Diagnosed Advanced Ovarian Cancer

As reported by Alexi A. Wright, MD, MPH, of Dana-Farber Cancer Institute, and colleagues in the Journal of Clinical Oncology, ASCO and the Society of Gynecologic Oncology (SGO) have released a clinical practice guideline on neoadjuvant therapy for patients with newly diagnosed stage IIIC or IV epithelial ovarian cancer. The recommendations are based on expert panel systematic review of the literature, with four phase III trials providing the primary evidence base for the recommendations. The panel was co-chaired by Dr. Wright and Mitchell I. Edelson, MD, of Hanjani Institute for … (leggi tutto)